Region 20q13.12, previously identified in other ovarian tumors, was amplified in our cohort, along with other genes that have previously found amplified in ovarian cancer such as CCNE1, ERBB2, RSF1 and deleted genes like BRCA18,22. This evidence concerns the gene ERBB2 and ovarian cancer.